Terms: = Lymphoma AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Prognosis
30 results:
1. TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.
Zhang Y; Wang ZZ; Han AQ; Yang MY; Zhu LX; Pan FM; Wang Y
Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):195-209. PubMed ID: 37806848
[TBL] [Abstract] [Full Text] [Related]
2. Ambra1 modulates the sensitivity of mantle cell lymphoma to palbociclib by regulating cyclin D1.
Jiang Z; Zhang A; Wei W; Li S
Sci Rep; 2023 May; 13(1):8389. PubMed ID: 37225761
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract] [Full Text] [Related]
4. Molecular and clinical diversity in primary central nervous system lymphoma.
Hernández-Verdin I; Kirasic E; Wienand K; Mokhtari K; Eimer S; Loiseau H; Rousseau A; Paillassa J; Ahle G; Lerintiu F; Uro-Coste E; Oberic L; Figarella-Branger D; Chinot O; Gauchotte G; Taillandier L; Marolleau JP; Polivka M; Adam C; Ursu R; Schmitt A; Barillot N; Nichelli L; Lozano-Sánchez F; Ibañez-Juliá MJ; Peyre M; Mathon B; Abada Y; Charlotte F; Davi F; Stewart C; de Reyniès A; Choquet S; Soussain C; Houillier C; Chapuy B; Hoang-Xuan K; Alentorn A
Ann Oncol; 2023 Feb; 34(2):186-199. PubMed ID: 36402300
[TBL] [Abstract] [Full Text] [Related]
5. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma.
Brivio E; Baruchel A; Beishuizen A; Bourquin JP; Brown PA; Cooper T; Gore L; Kolb EA; Locatelli F; Maude SL; Mussai FJ; Vormoor-Bürger B; Vormoor J; von Stackelberg A; Zwaan CM
Eur J Cancer; 2022 Mar; 164():1-17. PubMed ID: 35121370
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
[TBL] [Abstract] [Full Text] [Related]
7. The cdk4/6-UCHL5-BRD4 axis confers resistance to BET inhibitors in MLL-rearranged leukemia cells by suppressing BRD4 protein degradation.
Amari K; Sasagawa S; Imayoshi N; Toda Y; Hosogi S; Imamura T; Ashihara E
Biochem Biophys Res Commun; 2022 Jan; 588():147-153. PubMed ID: 34954522
[TBL] [Abstract] [Full Text] [Related]
8. Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract] [Full Text] [Related]
9. High-throughput proteomic profiling reveals mechanisms of action of AMG925, a dual FLT3-cdk4/6 kinase inhibitor targeting AML and AML stem/progenitor cells.
Zeng Z; Ly C; Daver N; Cortes J; Kantarjian HM; Andreeff M; Konopleva M
Ann Hematol; 2021 Jun; 100(6):1485-1496. PubMed ID: 33787984
[TBL] [Abstract] [Full Text] [Related]
10. Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell lymphoma.
Cann ML; Herring LE; Haar LL; Gilbert TSK; Goldfarb D; Richards KL; Graves LM; Lawrence DS
J Proteome Res; 2019 Jan; 18(1):522-534. PubMed ID: 30540191
[TBL] [Abstract] [Full Text] [Related]
11. In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida.
Ishikawa C; Mori N
Oncol Rep; 2017 Nov; 38(5):3197-3204. PubMed ID: 29048633
[TBL] [Abstract] [Full Text] [Related]
12. ICT1 predicts a poor survival and correlated with cell proliferation in diffuse large B-cell lymphoma.
Xie W; Wu M; Fu T; Li X; Wang Z; Hu Y; Zhu L; Zhang G
Gene; 2017 Sep; 627():255-262. PubMed ID: 28629825
[TBL] [Abstract] [Full Text] [Related]
13. [Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of T Cell Lymphoblastic lymphoma - Clinical observation of 10 Cases].
Gong F; Chen H; Zhao LY; Wang T; Zhang R; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1759-1763. PubMed ID: 28024490
[TBL] [Abstract] [Full Text] [Related]
14. The role of CDKN2A/B deletions in pediatric acute lymphoblastic leukemia.
Carrasco Salas P; Fernández L; Vela M; Bueno D; González B; Valentín J; Lapunzina P; Pérez-Martínez A
Pediatr Hematol Oncol; 2016; 33(7-8):415-422. PubMed ID: 27960642
[TBL] [Abstract] [Full Text] [Related]
15. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) CCND1-IGH: A case report and literature review.
Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of CREB Promotes Cell Proliferation by Mediating G1/S Phase Transition in Hodgkin lymphoma.
Lu F; Zheng Y; Donkor PO; Zou P; Mu P
Oncol Res; 2016; 24(3):171-9. PubMed ID: 27458098
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic impact of p15 gene aberrations in acute leukemia.
De Braekeleer M; Douet-Guilbert N; De Braekeleer E
Leuk Lymphoma; 2017 Feb; 58(2):257-265. PubMed ID: 27401303
[TBL] [Abstract] [Full Text] [Related]
18. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract] [Full Text] [Related]
19. High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.
Delfau-Larue MH; Klapper W; Berger F; Jardin F; Briere J; Salles G; Casasnovas O; Feugier P; Haioun C; Ribrag V; Thieblemont C; Unterhalt M; Dreyling M; Macintyre E; Pott C; Hermine O; Hoster E;
Blood; 2015 Jul; 126(5):604-11. PubMed ID: 26022239
[TBL] [Abstract] [Full Text] [Related]
20. The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.
Chien WW; Catallo R; Chebel A; Baranger L; Thomas X; Béné MC; Gerland LM; Schmidt A; Beldjord K; Klein N; Escoffre-Barbe M; Leguay T; Huguet F; Larosa F; Hayette S; Plesa A; Ifrah N; Dombret H; Salles G; Chassevent A; Ffrench M
Leuk Res; 2015 Apr; 39(4):453-61. PubMed ID: 25675863
[TBL] [Abstract] [Full Text] [Related]
[Next]